| European Case Law Identifier: | ECLI:EP:BA:1992:T050091.19921021 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 21 October 1992 | ||||||||
| Case number: | T 0500/91 | ||||||||
| Application number: | 81300050.2 | ||||||||
| IPC class: | C12N 15/00 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | B | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | DNA sequences, recombinant DNA molecules and processes for producing human interferon-alpha like polypeptides | ||||||||
| Applicant name: | Biogen N.V. | ||||||||
| Opponent name: | 01) F. Hoffmann-La-Roche & Co. 02) The Upjohn Company 03) Boehringer Ingelheim Zentrale GmbH 04) Bender & Co Ges mbH 05) Cetus Corporation/Triton Biosciences Inc. 06) Hoechst Aktiengesellschaft, Frankfurt 07) Boehringer Mannheim GmbH 09) Boehringer Ingelheim Pharma Ges mbH |
||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Inventive step (yes) - No realistic expectation of success - Activities to be expected from the notional person skilled in the art Assessment of evidence not a question of law |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t910500eu1.html
Date retrieved: 17 May 2021
